Free Trial
→ Musk’s Project Colossus could mint millionaires (From Brownstone Research) (Ad) Buy ABT Stock  Free ABT Stock Alerts

Abbott Laboratories (ABT) Short Interest Ratio & Short Volume

Abbott Laboratories logo
$133.23 +4.67 (+3.63%)
As of 03:47 PM Eastern
Compare

Abbott Laboratories Short Interest Data

Abbott Laboratories (ABT) has a short interest of 21.12 million shares, representing 1.22% of the float (the number of shares available for trading by the public). This marks a -2.63% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.0, indicating that it would take 3.0 days of the average trading volume of 6.12 million shares to cover all short positions.

Current Short Interest
21,120,000 shares
Previous Short Interest
21,690,000 shares
Change Vs. Previous Month
-2.63%
Dollar Volume Sold Short
$2.76 billion
Short Interest Ratio
3.0 Days to Cover
Last Record Date
April 30, 2025
Outstanding Shares
1,739,836,000 shares
Float Size
1,730,000,000 shares
Short Percent of Float
1.22%
Today's Trading Volume
5,419,967 shares
Average Trading Volume
6,124,389 shares
Today's Volume Vs. Average
88%
Short Selling Abbott Laboratories?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Abbott Laboratories and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ABT Short Interest Over Time

ABT Days to Cover Over Time

ABT Percentage of Float Shorted Over Time

Abbott Laboratories Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202521,120,000 shares $2.76 billion -2.6%1.2%3 $130.71
4/15/202521,690,000 shares $2.73 billion -0.5%1.3%2.9 $126.08
3/31/202521,790,000 shares $2.89 billion -0.4%1.3%3.1 $132.76
3/15/202521,880,000 shares $2.78 billion -4.6%1.3%3.3 $127.02
2/28/202522,930,000 shares $3.16 billion +2.8%1.3%3.7 $137.99
2/15/202522,310,000 shares $2.91 billion +22.3%1.3%3.9 $130.63
1/31/202518,240,000 shares $2.33 billion +21.8%1.1%3.2 $127.69
1/15/202514,970,000 shares $1.66 billion +4.5%0.9%2.7 $110.96
12/31/202414,320,000 shares $1.62 billion +18.4%0.8%2.9 $113.11
12/15/202412,100,000 shares $1.37 billion -10.8%0.7%2.4 $113.38
11/30/202413,570,000 shares $1.61 billion +12.6%0.8%2.7 $118.77
11/15/202412,050,000 shares $1.40 billion -14.4%0.7%2.4 $115.90
10/31/202414,070,000 shares $1.60 billion +0.6%0.8%2.9 $113.39
10/15/202413,980,000 shares $1.62 billion +18.2%0.8%2.5 $116.04
9/30/202411,830,000 shares $1.35 billion -11.5%0.7%2 $114.01
9/15/202413,360,000 shares $1.56 billion +4.8%0.8%2.2 $116.40
8/31/202412,750,000 shares $1.44 billion +0.6%0.7%2.1 $113.27
8/15/202412,680,000 shares $1.41 billion -7.0%0.7%2 $110.95
7/31/202413,630,000 shares $1.44 billion +26.8%0.8%2 $105.96
7/15/202410,750,000 shares $1.11 billion -17.3%0.6%1.8 $102.99
6/30/202413,000,000 shares $1.35 billion +11.9%0.8%2.3 $103.91
6/15/202411,620,000 shares $1.20 billion -19.9%0.7%2 $103.68
5/31/202414,500,000 shares $1.48 billion -1.8%0.8%2.4 $102.22
5/15/202414,770,000 shares $1.54 billion +2.0%0.9%2.6 $104.56
4/30/202414,480,000 shares $1.53 billion +11.9%0.8%2.6 $105.94
4/15/202412,940,000 shares $1.41 billion -10.6%0.8%2.2 $108.89
3/31/202414,480,000 shares $1.65 billion -7.9%0.8%2.5 $113.66
3/15/202415,720,000 shares $1.80 billion +5.4%0.9%2.9 $114.43
2/29/202414,920,000 shares $1.77 billion +4.4%0.9%3 $118.56
2/15/202414,290,000 shares $1.62 billion +12.5%0.8%2.7 $113.64
1/31/202412,700,000 shares $1.44 billion +20.4%0.7%2.3 $113.16
1/15/202410,550,000 shares $1.20 billion -11.2%0.6%1.9 $113.92
12/31/202311,880,000 shares $1.31 billion -3.5%0.7%2 $110.07
12/15/202312,310,000 shares $1.32 billion +4.8%0.7%2 $107.29
11/30/202311,750,000 shares $1.23 billion -2.7%0.7%2 $104.30
11/15/202312,080,000 shares $1.18 billion +22.3%0.7%2.2 $98.00
10/31/20239,880,000 shares $934.15 million +1.9%0.6%1.9 $94.55
10/15/20239,700,000 shares $881.44 million -4.7%0.6%2 $90.87
9/30/202310,180,000 shares $985.93 million -4.1%0.6%2.3 $96.85
9/15/202310,610,000 shares $1.08 billion -7.5%0.6%2.4 $101.76
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Revolution we predicted has arrived." In fact, I believe these robots could impact 65 million Americans lives — by August of this year.

I'll tell you more about the $7 company Huang and Nvidia joined forces with to make it happen.
8/31/202311,470,000 shares $1.18 billion -10.2%0.7%2.5 $102.90
8/15/202312,770,000 shares $1.34 billion +6.0%0.7%2.6 $104.93
7/31/202312,050,000 shares $1.34 billion +9.4%0.7%2.5 $111.34
7/15/202311,020,000 shares $1.19 billion -16.6%0.6%2.3 $107.93
6/30/202313,220,000 shares $1.44 billion +11.8%0.8%2.7 $109.02
6/15/202311,820,000 shares $1.24 billion -12.0%0.7%2.3 $105.04
5/31/202313,430,000 shares $1.37 billion +3.7%0.8%2.6 $102.00
5/15/202312,950,000 shares $1.42 billion +15.2%0.8%2.5 $109.84
4/30/202311,240,000 shares $1.24 billion -10.8%0.7%2.1 $110.47
4/15/202312,600,000 shares $1.31 billion No Change0.7%2.3 $103.96
3/31/202312,600,000 shares $1.28 billion -1.9%0.7%2.4 $101.26
3/15/202312,840,000 shares $1.26 billion -7.8%0.7%2.6 $97.80
2/28/202313,930,000 shares $1.42 billion +5.6%0.8%2.9 $101.72
2/15/202313,190,000 shares $1.42 billion +9.9%0.8%2.8 $107.28
1/31/202312,000,000 shares $1.33 billion -17.8%0.7%2.5 $110.55
1/15/202314,600,000 shares $1.66 billion -12.5%0.8%2.8 $113.51
12/30/202216,680,000 shares $1.83 billion -7.8%1.0%3 $109.79
12/15/202218,090,000 shares $1.96 billion +14.9%1.1%3.1 $108.52
11/30/202215,740,000 shares $1.69 billion +0.6%0.9%2.6 $107.58
11/15/202215,650,000 shares $1.61 billion +10.3%0.9%2.6 $103.14
10/31/202214,190,000 shares $1.40 billion +1.4%0.8%2.5 $98.94
10/15/202213,990,000 shares $1.41 billion -16.9%0.8%2.6 $100.91
9/30/202216,830,000 shares $1.63 billion +5.0%1.0%3.5 $96.76
9/15/202216,030,000 shares $1.68 billion +23.9%0.9%3.4 $105.06
8/31/202212,940,000 shares $1.33 billion -8.1%0.7%2.7 $102.65
8/15/202214,080,000 shares $1.58 billion +1.7%0.8%3 $111.90
7/31/202213,840,000 shares $1.51 billion -2.7%0.8%2.7 $108.84
7/15/202214,220,000 shares $1.55 billion +9.6%0.8%2.6 $108.82
6/30/202212,980,000 shares $1.41 billion -7.4%0.8%2.4 $108.65
6/15/202214,020,000 shares $1.47 billion +2.6%0.8%2.6 $104.80
5/31/202213,670,000 shares $1.61 billion +0.7%0.8%2.6 $117.46
5/15/202213,570,000 shares $1.49 billion +0.8%0.8%2.4 $109.88
4/30/202213,460,000 shares $1.53 billion +5.2%0.8%2.5 $113.50
4/15/202212,790,000 shares $1.51 billion +5.7%0.7%2.1 $117.69
3/31/202212,100,000 shares $1.43 billion -9.2%0.7%2 $118.36
3/15/202213,330,000 shares $1.57 billion +28.4%0.8%2.2 $117.48
2/28/202210,380,000 shares $1.25 billion +0.1%0.6%1.6 $120.62
2/15/202210,370,000 shares $1.29 billion +15.4%0.6%1.7 $123.98
1/31/20228,990,000 shares $1.15 billion -0.2%0.5%1.5 $127.46
1/15/20229,010,000 shares $1.15 billion +7.4%0.5%1.6 $128.16
12/31/20218,390,000 shares $1.18 billion -13.3%0.5%1.6 $140.74
12/15/20219,680,000 shares $1.31 billion +11.1%0.6%1.8 $135.56
11/30/20218,710,000 shares $1.10 billion -14.1%0.5%1.7 $125.77
11/15/202110,140,000 shares $1.31 billion -9.7%0.6%2 $129.44
10/29/202111,230,000 shares $1.45 billion +7.0%N/A2.3 $128.89
10/15/202110,500,000 shares $1.23 billion -6.4%0.6%2.3 $117.49
9/30/202111,220,000 shares $1.33 billion +1.5%0.6%2.4 $118.13
9/15/202111,050,000 shares $1.41 billion +8.1%0.6%2.4 $127.49
8/31/202110,220,000 shares $1.29 billion -7.0%0.6%2.1 $126.37
8/13/202110,990,000 shares $1.35 billion -8.0%0.6%1.8 $123.06
The Robotics Revolution has arrived … and one $7 stock could take off as a result. (Ad)

Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Revolution we predicted has arrived." In fact, I believe these robots could impact 65 million Americans lives — by August of this year.

I'll tell you more about the $7 company Huang and Nvidia joined forces with to make it happen.
7/30/202111,940,000 shares $1.44 billion +2.8%0.7%2 $120.98
7/15/202111,620,000 shares $1.36 billion -14.2%0.7%1.9 $116.66
6/30/202113,550,000 shares $1.57 billion -3.3%0.8%2.2 $115.93
6/15/202114,010,000 shares $1.55 billion -3.8%0.8%2.3 $110.41
5/28/202114,570,000 shares $1.70 billion +2.6%0.8%2.5 $116.65
5/14/202114,200,000 shares $1.67 billion +1.5%N/A2.9 $117.45
4/30/202113,990,000 shares $1.69 billion -4.2%N/A2.8 $121.01
4/15/202114,600,000 shares $1.77 billion +7.0%N/A2.8 $121.50
3/31/202113,640,000 shares $1.63 billion +7.2%N/A2.6 $119.75
3/15/202112,730,000 shares $1.49 billion +30.0%N/A2.5 $116.71
2/26/20219,790,000 shares $1.19 billion -6.7%N/A1.9 $121.58
2/12/202110,490,000 shares $1.33 billion -8.9%N/A2.1 $126.84
1/29/202111,520,000 shares $1.39 billion +29.4%N/A2.3 $120.39
1/15/20218,900,000 shares $979.36 million -10.5%N/A1.8 $110.04
12/31/20209,940,000 shares $1.08 billion +11.9%N/A2.1 $108.44
12/15/20208,880,000 shares $948.30 million -9.1%N/A1.8 $106.79
11/30/20209,770,000 shares $1.05 billion -17.6%N/A2 $107.62
11/15/202011,850,000 shares $1.33 billion +19.5%N/A2.1 $112.60
10/30/20209,920,000 shares $1.04 billion +5.6%N/A1.8 $105.00
10/15/20209,390,000 shares $1.01 billion -0.5%N/A1.8 $107.75
9/30/20209,440,000 shares $1.03 billion +8.8%N/A1.8 $108.83
9/15/20208,680,000 shares $925.11 million -16.5%N/A1.6 $106.58
8/31/202010,400,000 shares $1.14 billion +3.1%N/A1.9 $109.47
8/14/202010,090,000 shares $1.01 billion -20.6%N/A2 $99.99
7/31/202012,710,000 shares $1.28 billion +25.0%N/A2.2 $100.64
7/15/202010,170,000 shares $983.74 million -6.7%0.6%1.6 $96.73
6/30/202010,900,000 shares $996.59 million -15.0%N/A1.4 $91.43
6/15/202012,820,000 shares $1.15 billion -13.7%N/A1.4 $89.55
5/29/202014,860,000 shares $1.41 billion -18.0%N/A1.4 $94.92
5/15/202018,120,000 shares $1.63 billion -7.4%N/A1.6 $89.89

ABT Short Interest - Frequently Asked Questions

What is Abbott Laboratories' current short interest?

Short interest is the volume of Abbott Laboratories shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 21,120,000 shares of ABT short. 1.22% of Abbott Laboratories' shares are currently sold short. Learn More on Abbott Laboratories' current short interest.

What is a good short interest ratio for Abbott Laboratories?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABT shares currently have a short interest ratio of 3.0. Learn More on Abbott Laboratories's short interest ratio.

Which institutional investors are shorting Abbott Laboratories?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Abbott Laboratories: Susquehanna International Group LLP, HAP Trading LLC, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Jane Street Group LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Garda Capital Partners LP, Credit Agricole S A, Maven Securities LTD, Arrowpoint Investment Partners Singapore Pte. Ltd., Simplex Trading LLC, JPMorgan Chase & Co., Locust Wood Capital Advisers LLC, Wolverine Asset Management LLC, Citigroup Inc., XY Capital Ltd, Delta Accumulation LLC, Gladius Capital Management LP, Readystate Asset Management LP, Allianz Asset Management GmbH, SteelPeak Wealth LLC, Fulcrum Asset Management LLP, Wealth Enhancement Advisory Services LLC, Arrowpoint Investment Partners Singapore Pte. Ltd., Wolverine Trading LLC, Squarepoint Ops LLC, Point72 Asset Management L.P., Man Group plc, Maven Securities LTD, Millennium Management LLC, Moore Capital Management LP, LMR Partners LLP, Group One Trading LLC, Eisler Capital Management Ltd., Cubist Systematic Strategies LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Paloma Partners Management Co, Lido Advisors LLC, Tudor Investment Corp ET AL, Parallax Volatility Advisers L.P., Susquehanna International Group LLP, HAP Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Abbott Laboratories?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.22% of Abbott Laboratories' floating shares are currently sold short.

Is Abbott Laboratories' short interest increasing or decreasing?

Abbott Laboratories saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 21,120,000 shares, a decrease of 2.6% from the previous total of 21,690,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Abbott Laboratories' float size?

Abbott Laboratories currently has issued a total of 1,739,836,000 shares. Some of Abbott Laboratories' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Abbott Laboratories currently has a public float of 1,730,000,000 shares.

How does Abbott Laboratories' short interest compare to its competitors?

1.22% of Abbott Laboratories' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Abbott Laboratories: Intuitive Surgical, Inc. (1.31%), Boston Scientific Co. (1.07%), Stryker Co. (1.75%), Medtronic plc (0.96%), Becton, Dickinson and Company (1.27%), Edwards Lifesciences Co. (1.43%), IDEXX Laboratories, Inc. (3.61%), ResMed Inc. (6.25%), DexCom, Inc. (2.93%), STERIS plc (1.54%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Strategy Incorporated ($10.45 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), Apollo Global Management, Inc. ($3.83 billion), The Kroger Co. ($2.56 billion), Hims & Hers Health, Inc. ($2.06 billion), Dell Technologies Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.90 billion), Amcor plc ($1.76 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks.

What does it mean to sell short Abbott Laboratories stock?

Short selling ABT is an investing strategy that aims to generate trading profit from Abbott Laboratories as its price is falling. ABT shares are trading up $3.86 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Abbott Laboratories?

A short squeeze for Abbott Laboratories occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABT, which in turn drives the price of the stock up even further.

How often is Abbott Laboratories' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABT, twice per month. The most recent reporting period available is April, 30 2025.



Related Companies
Short Interest Tools

This page (NYSE:ABT) was last updated on 5/15/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Silver Demand Is Soaring-Supply Can't Keep Up
Silver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...
i2i Marketing Group, LLC | Sponsored
Shocking AI play that’s beats Nvidia by a country mile
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...
Timothy Sykes | Sponsored
The Man I Turn to In Times Like This
A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...
Stansberry Research | Sponsored